Between the Bells
Tune in to the Bell Direct 'Between the Bells' podcast, where we'll cover the latest economic news and updates, market movements and analysis. With daily updates, you can get the information you need to find your investing edge.
Find Bell Direct here:
Website: https://www.belldirect.com.au/smarter/
Twitter: https://twitter.com/belldirect
Facebook: https://www.facebook.com/BellDirectAustralia
LinkedIn: https://www.linkedin.com/company/bell-direct/
Instagram: https://www.instagram.com/bell.direct/
Episodes
1682 episodes
From the helm: Centaurus Metals (ASX:CTM), CEO & MD, Darren Gordon
In this episode of From the helm, Sophia Mavridis is joined by Centaurus Metals (ASX:CTM) CEO & MD Darren Gordon to discuss what sets their product apart from its peers and what is next for the broader nickel market.
•
6:33
From the helm: Oneview Healthcare (ASX:ONE), CEO, James Fitter
In this episode of From the helm, Sophia Mavridis sits down with Oneview Healthcare (ASX:ONE) CEO James Fitter to unpack their unique end-to-end patient monitoring technology, the impact of AI emergence on their business and what’s to come look...
•
4:25
From the helm: Titomic Ltd, CFO, Geoff Hollis
In this episode of From the helm, Titomic (ASX:TTT) CFO Geoff Hollis joins us for a deep dive into their proprietary technology for the manufacture of metal parts, including how it differentiates from other products in the market and what is on...
•
8:34
From the helm: Artrya Limited (ASX:AYA): John Konstantopoulos, CEO & Co-Founder
In this episode of From the Helm, John Konstantopoulos, CEO & Co-Founder of Artrya Limited (ASX:AYA), joins us to discuss the company’s AI-powered approach to transforming cardiac diagnostics and improving patient outcomes.John prov...
•
7:58
From the helm: Bell Financial Group (ASX:BFG): Arnie Selvarajah, Group Co-CEO
In this episode of From the Helm, Arnie Selvarajah, Group Co-CEO of Bell Financial Group (ASX:BFG), joins us to discuss the company’s evolution into a more diversified and holistic wealth manager.Arnie unpacks the strategic shift beyond...
•
9:46
Navigating geopolitical turbulence:The strategic case for defence technology
With countries across the world committing more spend to their military, gaining exposure to the defence sector has increasingly become a key strategy for investors. As the escalating US-Iran conflict has been making headlines, this secto...
•
17:14
Weekly Wrap 27 March
In today’s Weekly Wrap episode, Will Riggall and Sophia Mavridis chat about the key insights heard at the ASX SMIDcaps conference this week, proudly sponsored by Bell Financial Group.Our CIO Will Riggall and Lead Strategist Rob Crooksto...
•
12:45
From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.
In this episode of From the Helm, Grady sits down with Summerset Group Holdings (ASX:SNZ) CFO Margaret Warrington to unpack their end-to-end business model for aged care sites, from land acquisition all the way through to building and operating...
•
10:57
From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
In this episode of From the Helm, Grady is joined by Amplia Therapeutics (ASX:ATX) CEO & MD Dr Christopher Burns & Bell Potter Analyst Thomas Wakim to unpack the ongoing clinical trials for their prospective treatment drug for pan...
•
13:49
From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.
In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive diseas...
•
11:10
From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.
In this episode of From the Helm, Grady sits down with Neuren Pharmaceuticals (ASX:NEU) CEO Jon Pilcher, to recap on their major developments over the last 12 months in the US market, their guidance looking ahead for next financial year, and th...
•
15:25
From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan
In this episode of From the Helm, Grady chats with Saluda Medical (ASX:SM1) President and CEO Barry Regan to discuss their recent developments since their IPO in November, their developmental drug for the treatment of chronic pain, and what is ...
•
17:10
From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester
In this episode of From the Helm, Grady is joined by Clarity Pharmaceuticals (ASX:CU6) Executive Chairperson Alan Taylor & Bell Potter Senior Analyst John Hester, for a deep dive into their next-generation radiopharmaceutical technology for...
•
16:12
From the helm: Mesoblast (ASX:MSB), Director, Silviu Itescu
In this episode of From the Helm, Grady sits down with Mesoblast Director Silviu Itescu, to unpack the recent approval and launch of their Ryoncil drug for children, their outlook for the next 12 months in capturing the adult market, and their ...
•
8:48
From the helm: 4DMedical (ASX:4DX), Founder & CEO, Andreas Fouras
In this episode of From the helm, Grady chats with 4D Medical (ASX:4DX) Founder and CEO Andreas Fouras to reflect on the meteoric rise of their lung imaging technology and detail their future plans for further global expansion.
•
12:53
From the helm: EBR Systems (ASX:EBR), President & CEO, John McCutcheon
In this episode of From the Helm, Grady sits down with EBR Systems (ASX:EBR) President and CEO John McCutcheon, to discuss their innovative, one-of-a-kind implant treatment for heart failure patients, the pathway to widespread adoption, and sca...
•
7:24
Weekly Wrap 20 March
While global markets remain focused on the latest central bank moves, rising energy prices and geopolitical shifts are adding a new layer of complexity to the inflation outlook. This week, Sophia Mavridis is joined by Bell Financial Group’s CIO...
•
8:46
Weekly Wrap 13 March
As the Middle East conflict entered another week the market saw its greatest volatility yet, with Monday bringing about the worst single day drop since the COVID pandemic of 2020.Today, Sophia Mavridis sat down with Bell Financial Group’...
•
7:54
Morning Bell 12 March
Wall St saw a mixed session overnight as the US – Iran war and oil price volatility continued to weigh on investors. The Dow Jones closed down 0.6%, the S&P500 inched down 0.1%, while the Nasdaq gained 0.1%.What to watch today:
•
2:24
Morning Bell 11 March
Wall St overnight saw a very slight pullback after a choppy trading session, as trader remained wary of developments in the ongoing Iran war. The S&P500 dropped 0.2% by close of trade, the Dow Jones dropped 0.1%, and the Nasdaq ended the tr...
•
2:20
Morning Bell 10 March
US equities rallied late in the trading session following President Donald Trump’s comments to CBS News that he thinks the war against Iran could soon end. The headlines steadied global markets and all three major benchmarks closed in the green...
•
2:43
Morning Bell 9 March
We’re poised for a rough start to the week, after Wall St saw a sizeable drop last Friday to cap off a highly volatile week. The Dow Jones lost 1%, the S&P500 fell 1.3%, while the Nasdaq lost 1.6%. On top of the ramifications of the ongoing...
•
2:24
Week 4: Geopolitical conflicts, plus a reporting season wrap with Bell Financial Group’s CIO Will Riggall
The conflict in the Middle East intensified this week, resulting in broad-based market instability and a drop in global equities. This week, Sophia Mavridis sits down with Bell Financial Group’s CIO Will Riggall, to unpack how markets historica...
•
8:37